A detailed history of Voya Financial Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Voya Financial Advisors, Inc. holds 10,687 shares of AZN stock, worth $717,952. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,687
Previous 11,859 9.88%
Holding current value
$717,952
Previous $924,000 9.96%
% of portfolio
0.09%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.67 - $87.62 $89,857 - $102,690
-1,172 Reduced 9.88%
10,687 $832,000
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $10,956 - $13,256
-164 Reduced 1.36%
11,859 $924,000
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $7,750 - $8,835
127 Added 1.07%
12,023 $814,000
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $10,583 - $11,846
171 Added 1.46%
11,896 $801,000
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $29,312 - $32,408
-452 Reduced 3.71%
11,725 $794,000
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $3,145 - $3,411
45 Added 0.37%
12,177 $871,000
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $27,028 - $30,644
428 Added 3.66%
12,132 $842,000
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $79,634 - $103,476
1,469 Added 14.35%
11,704 $793,000
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $24,707 - $63,259
466 Added 4.77%
10,235 $562,000
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $105,245 - $126,344
1,776 Added 22.22%
9,769 $655,000
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $183,430 - $220,959
3,292 Added 70.03%
7,993 $536,000
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $253,948 - $300,064
4,701 New
4,701 $275,000
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $399,513 - $496,545
-8,251 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $350,540 - $404,652
-7,433 Reduced 47.39%
8,251 $412,000
Q4 2020

Mar 05, 2021

SELL
$48.52 - $58.02 $47,937 - $57,323
-988 Reduced 5.93%
15,684 $787,000
Q3 2020

Nov 16, 2020

BUY
$53.07 - $61.1 $226,980 - $261,324
4,277 Added 34.51%
16,672 $919,000
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $6,594 - $8,462
153 Added 1.25%
12,395 $656,000
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $153,276 - $208,194
4,056 Added 49.55%
12,242 $545,000
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $28,702 - $34,110
676 Added 9.0%
8,186 $409,000
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $10,631 - $12,049
265 Added 3.66%
7,510 $340,000
Q2 2019

Aug 14, 2019

BUY
$37.28 - $41.68 $2,199 - $2,459
59 Added 0.82%
7,245 $297,000
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $379,033 - $459,453
-10,680 Reduced 59.78%
7,186 $309,000
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $49,281 - $55,472
-1,337 Reduced 6.96%
17,866 $675,000
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $423,446 - $483,869
-12,182 Reduced 38.81%
19,203 $763,000
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $240,053 - $257,423
-6,948 Reduced 18.13%
31,385 $1.1 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $32,244 - $35,824
978 Added 2.62%
38,333 $1.35 Million
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $235,348 - $255,076
7,334 Added 24.43%
37,355 $1.27 Million
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $869,408 - $1.02 Million
30,021
30,021 $1.01 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Voya Financial Advisors, Inc. Portfolio

Follow Voya Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.